Loading...
Reimbursement for bone loss prevention is different between women with breast cancer and men with prostate cancer: time for a revision
The hormone dependent breast and prostate cancers have in general a very good survival, due to the anti-hormonal treatment. A disadvantage of this treatment is the increased risk of osteoporosis and fractures. It is surprisingly to note that denosumab has the same impact on fracture reduction incide...
Na minha lista:
| Udgivet i: | Facts Views Vis Obgyn |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Universa Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4788334/ https://ncbi.nlm.nih.gov/pubmed/26977268 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|